HPR21 Project Orbis the UK: 18-Month Report Card – Implications of UK Market Access for Oncology Drugs Prior to Europe
Dec 1, 2022, 00:00 AM
10.1016/j.jval.2022.09.1153
https://www.valueinhealthjournal.com/article/S1098-3015(22)03358-7/fulltext
Section Title :
Section Order :
10701
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)03358-7&doi=10.1016/j.jval.2022.09.1153